Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global MRNA Vaccines & Therapeutics market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
MRNA Vaccines & Therapeutics market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The MRNA Vaccines & Therapeutics market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the MRNA Vaccines & Therapeutics products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of MRNA Vaccines & Therapeutics products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the MRNA Vaccines & Therapeutics market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on MRNA Vaccines & Therapeutics development has been the leading industry trend of MRNA Vaccines & Therapeutics market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global MRNA Vaccines & Therapeutics Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Standardization Of Cancer Treatment MRNA Vaccine,Individualized Cancer Treatment MRNA Vaccine,Infectious Disease Treatment MRNA Vaccine,Infection Prevention MRNA Vaccine |
| By Application Outlook |
Infectious Disease,Cancer,Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Moderna Therapeutics,CureVac,Translate Bio,BioNTech,Sangamo Therapeutics,Argos Therapeutics,In-Cell-Art,eTheRNA,Ethris,Tiba Biotechnology |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Moderna Therapeutics
- CureVac
- Translate Bio
- BioNTech
- Sangamo Therapeutics
- Argos Therapeutics
- In-Cell-Art
- eTheRNA
- Ethris
- Tiba Biotechnology
MRNA Vaccines & Therapeutics Market, By Type
- Standardization Of Cancer Treatment MRNA Vaccine
- Individualized Cancer Treatment MRNA Vaccine
- Infectious Disease Treatment MRNA Vaccine
- Infection Prevention MRNA Vaccine
MRNA Vaccines & Therapeutics Market, By Application
- Infectious Disease
- Cancer
- Other
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
Global mRNA Vaccines & Therapeutics Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 mRNA Vaccines & Therapeutics Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 mRNA Vaccines & Therapeutics Industry Overview
2.1 Global mRNA Vaccines & Therapeutics Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 mRNA Vaccines & Therapeutics Global Import Market Analysis
2.1.2 mRNA Vaccines & Therapeutics Global Export Market Analysis
2.1.3 mRNA Vaccines & Therapeutics Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Standardization Of Cancer Treatment MRNA Vaccine
2.2.2 Individualized Cancer Treatment MRNA Vaccine
2.2.3 Infectious Disease Treatment MRNA Vaccine
2.2.4 Infection Prevention MRNA Vaccine
2.3.2 Cancer
2.3.3 Other
2.4.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global mRNA Vaccines & Therapeutics Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 mRNA Vaccines & Therapeutics Manufacturer Market Share
2.4.5 Top 10 mRNA Vaccines & Therapeutics Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into mRNA Vaccines & Therapeutics Market
2.4.7 Key Manufacturers mRNA Vaccines & Therapeutics Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 mRNA Vaccines & Therapeutics Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 mRNA Vaccines & Therapeutics Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global mRNA Vaccines & Therapeutics Market Size Categorized by Regions
4.1 Global mRNA Vaccines & Therapeutics Revenue, Sales and Market Share by Regions
4.1.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Regions (2015-2020)
4.1.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Regions (2015-2020)
4.2 Europe mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
4.3 APAC mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
4.4 North America mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
4.5 South America mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
5 Europe mRNA Vaccines & Therapeutics Market Size Categorized by Countries
5.1 Europe mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Countries
5.1.1 Europe mRNA Vaccines & Therapeutics Sales by Countries (2015-2020)
5.1.2 Europe mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020)
5.1.3 Germany mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
5.1.4 UK mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
5.1.5 France mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
5.1.6 Russia mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
5.1.7 Italy mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
5.1.8 Spain mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
5.2 Europe mRNA Vaccines & Therapeutics Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)
5.3.2 Europe mRNA Vaccines & Therapeutics Revenue and Revenue Share by Type (2015-2020)
5.4 Europe mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)
6 Asia-Pacific mRNA Vaccines & Therapeutics Market Size Categorized by Countries
6.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales by Countries (2015-2020)
6.1.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020)
6.1.3 China mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
6.1.4 Japan mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
6.1.5 Korea mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
6.1.6 India mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
6.1.8 Australia mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Market Share by Application (2015-2020)
7 North America mRNA Vaccines & Therapeutics Market Size Categorized by Countries
7.1 North America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Countries
7.1.1 North America mRNA Vaccines & Therapeutics Sales by Countries (2015-2020)
7.1.2 North America mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020)
7.1.3 United States mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
7.1.4 Canada mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
7.1.5 Mexico mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
7.2 North America mRNA Vaccines & Therapeutics Revenue (Value) by Manufacturers (2018-2020)
7.3 North America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)
7.3.2 North America mRNA Vaccines & Therapeutics Revenue and Revenue Share by Type (2015-2020)
7.4 North America mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)
8 South America mRNA Vaccines & Therapeutics Market Size Categorized by Countries
8.1 South America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Countries
8.1.1 South America mRNA Vaccines & Therapeutics Sales by Countries (2015-2020)
8.1.2 South America mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020)
8.1.3 Brazil mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
8.2 South America mRNA Vaccines & Therapeutics Revenue (Value) by Manufacturers (2018-2020)
8.3 South America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)
8.3.2 South America mRNA Vaccines & Therapeutics Revenue and Revenue Share by Type (2015-2020)
8.4 South America mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)
9 Middle East and Africa mRNA Vaccines & Therapeutics Market Size Categorized by Countries
9.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Countries (2015-2020)
9.1.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020)
9.1.3 GCC Countries mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
9.1.4 Turkey mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
9.1.5 Egypt mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
9.1.6 South Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)
10 Global mRNA Vaccines & Therapeutics Market Segment by Type
10.1 Global mRNA Vaccines & Therapeutics Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Type (2015-2020)
10.1.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Standardization Of Cancer Treatment MRNA Vaccine Sales Growth Rate and Price
10.2.1 Global Standardization Of Cancer Treatment MRNA Vaccine Sales Growth Rate (2015-2020)
10.2.2 Global Standardization Of Cancer Treatment MRNA Vaccine Price (2015-2020)
10.3 Individualized Cancer Treatment MRNA Vaccine Sales Growth Rate and Price
10.3.1 Global Individualized Cancer Treatment MRNA Vaccine Sales Growth Rate (2015-2020)
10.3.2 Global Individualized Cancer Treatment MRNA Vaccine Price (2015-2020)
10.4 Infectious Disease Treatment MRNA Vaccine Sales Growth Rate and Price
10.4.1 Global Infectious Disease Treatment MRNA Vaccine Sales Growth Rate (2015-2020)
10.4.2 Global Infectious Disease Treatment MRNA Vaccine Price (2015-2020)
10.5 Infection Prevention MRNA Vaccine Sales Growth Rate and Price
10.5.1 Global Infection Prevention MRNA Vaccine Sales Growth Rate (2015-2020)
10.5.2 Global Infection Prevention MRNA Vaccine Price (2015-2020)
11.1 Global mRNA Vaccines & TherapeuticsSales Market Share by Application (2015-2020)
11.2 Infectious Disease Sales Growth Rate (2015-2020)
11.3 Cancer Sales Growth Rate (2015-2020)
11.4 Other Sales Growth Rate (2015-2020)
12.1 Global mRNA Vaccines & Therapeutics Revenue, Sales and Growth Rate (2020-2027)
12.2 mRNA Vaccines & Therapeutics Market Forecast by Regions (2020-2027)
12.2.1 Europe mRNA Vaccines & Therapeutics Market Forecast (2020-2027)
12.2.2 APAC mRNA Vaccines & Therapeutics Market Forecast (2020-2027)
12.2.3 North America mRNA Vaccines & Therapeutics Market Forecast (2020-2027)
12.2.4 South America mRNA Vaccines & Therapeutics Market Forecast (2020-2027)
12.2.5 Middle East & Africa mRNA Vaccines & Therapeutics Market Forecast (2020-2027)
12.3 mRNA Vaccines & Therapeutics Market Forecast by Type (2020-2027)
12.3.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2020-2027)
12.3.2 Global mRNA Vaccines & Therapeutics Market Share Forecast by Type (2020-2027)
12.4 mRNA Vaccines & Therapeutics Market Forecast by Application (2020-2027)
12.4.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2020-2027)
12.4.2 Global mRNA Vaccines & Therapeutics Market Share Forecast by Application (2020-2027)
13 Analysis of mRNA Vaccines & Therapeutics Industry Key Manufacturers
13.1 Moderna Therapeutics
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Moderna Therapeutics News
13.2 CureVac
13.2.1 Company Details
13.2.2 Product Information
13.2.3 CureVac mRNA Vaccines & Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 CureVac News
13.3 Translate Bio
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Translate Bio mRNA Vaccines & Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Translate Bio News
13.4 BioNTech
13.4.1 Company Details
13.4.2 Product Information
13.4.3 BioNTech mRNA Vaccines & Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 BioNTech News
13.5 Sangamo Therapeutics
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Sangamo Therapeutics News
13.6 Argos Therapeutics
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Argos Therapeutics News
13.7 In-Cell-Art
13.7.1 Company Details
13.7.2 Product Information
13.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 In-Cell-Art News
13.8 eTheRNA
13.8.1 Company Details
13.8.2 Product Information
13.8.3 eTheRNA mRNA Vaccines & Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 eTheRNA News
13.9 Ethris
13.9.1 Company Details
13.9.2 Product Information
13.9.3 Ethris mRNA Vaccines & Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 Ethris News
13.10 Tiba Biotechnology
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 Tiba Biotechnology News
15 Appendix
